Skip to main content
Sartorius Stedim Biotech S.A. (EPA:DIM)
France flag France · Delayed Price · Currency is EUR
164.60
-5.55 (-3.26%)
At close: Mar 6, 2026

Sartorius Stedim Biotech Revenue

In the year 2025, Sartorius Stedim Biotech had annual revenue of 2.97B EUR with 6.74% growth. Sartorius Stedim Biotech had revenue of 772.20M in the quarter ending December 31, 2025, with 2.78% growth.

Revenue
2.97B
Revenue Growth
+6.74%
P/S Ratio
5.40
Revenue / Employee
296.48K
Employees
10,265
Market Cap
16.01B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.97B187.50M6.74%
Dec 31, 20242.78B4.50M0.16%
Dec 31, 20232.78B-717.20M-20.53%
Dec 31, 20223.49B605.70M20.98%
Dec 31, 20212.89B976.92M51.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
EssilorLuxottica Société anonyme 28.49B
Sanofi 46.72B
Ipsen 3.93B
Eurofins Scientific SE 7.30B
bioMérieux 4.07B
ABIVAX Société Anonyme 5.31M
Virbac 1.43B
emeis Société anonyme 5.77B
Revenue Rankings

Sartorius Stedim Biotech News

More News